Report overview
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U?) in 1969, followed by trabectedin (Yondelis?),eribulin mesylate (Halaven?), brentuximab vedotin (Adcetris?), and midostaurin (Rydapt?) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
This report aims to provide a comprehensive presentation of the global market for Marine Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Derived Drugs. This report contains market size and forecasts of Marine Derived Drugs in global, including the following market information:
Global Marine Derived Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Marine Derived Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Marine Derived Drugs companies in 2022 (%)
The global Marine Derived Drugs market was valued at US$ 2410.8 million in 2022 and is projected to reach US$ 4246 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
We surveyed the Marine Derived Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Marine Derived Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Marine Derived Drugs Market Segment Percentages, by Type, 2022 (%)
Mollusk
Sponge
Tunicate
Fish
Others
Global Marine Derived Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Marine Derived Drugs Market Segment Percentages, by Application, 2022 (%)
Antitumor Drugs
Anti-Cardiovascular Drugs
Others
Global Marine Derived Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Marine Derived Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Marine Derived Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Marine Derived Drugs revenues share in global market, 2022 (%)
Key companies Marine Derived Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Marine Derived Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Seattle Genetics
Eisai Co
Tekada
Pfizer
Pharma Mar
Johnson and Johnson
GSK
TerSera Therapeutics
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Marine Derived Drugs, market overview.
Chapter 2: Global Marine Derived Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Marine Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Marine Derived Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
